Learn More at www.morphogen-ix.com

Overview

Morphogen-IX is developing MGX292, a protein-engineered variant of human bone morphogenetic protein-9 (BMP9), for the treatment of pulmonary arterial hypertension (PAH).

Target Validation

Human Genetics

patients (us + eu) disease genetic source Univation affiliate
70,000 Pulmonary Arterial Hypertension (PAH) BMP9 Synthetic cPMP (ScPMP)

Overview

Morphogen-IX is www.morphogen-ix.com, a protein-engineered variant of human bone morphogenetic protein-9 (BMP9), for the treatment of pulmonary arterial hypertension (PAH).